Clinical Trial Update: Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction [NA]

View source ↗

Summary

A completed clinical trial evaluating optimized injections of OnabotulinumtoxinA for neurogenic lower urinary tract dysfunction has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Bladder
• Neurogenic Detrusor Overactivity
• Overactive Bladder

Drugs mentioned

• OnabotulinumtoxinA (Botox) (Botulinum toxin type A)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Neurogenic Bladder, Lower Urinary Tract Symptoms | NA | Status: COMPLETED | Results posted: 2025-05-09